On July 11, the signing ceremony of "Academician Liu Liang - Jiangyin Traditional Chinese Medicine Industry Research Center" was held in Jiangyin Municipal People's Government. Professor Liu Liang is an academician of the Chinese Academy of Engineering, honorary president of Macau University of Science and Technology, and chief scientist of Guangdong Academy of Chinese Medicine.
General Manager Hu Qifei of Tianjiang Pharmaceutical pointed out in the project construction report of "Academician Liu Liang - Jiangyin Traditional Chinese Medicine Industry Research Center": the completion of the research center will give full play to the research and development advantages of Academician Liu Liang's team.
The two parties will jointly carry out research on major key common technologies of traditional Chinese medicine and the development of a series of health products, so as to realize traditional Chinese medicine including planting of traditional Chinese medicines, processing of Chinese herbal decoction pieces, production of traditional Chinese medicine formula granules, manufacturing of Chinese patent medicines and general health products, and traditional Chinese medicine health services. The overall improvement of the technical capabilities of the entire industry chain will enhance the core competitiveness of Tianjiang Pharmaceutical products in the field of traditional Chinese medicine.
Academician Liu Liang introduced the team's research direction and R&D advantages in detail in his speech. He said that at the time of comprehensively promoting the construction of "Healthy China" and promoting the inheritance and innovation of traditional Chinese medicine, the team will carry out in-depth cooperation with Tianjiang Pharmaceutical to establish the Jiangyin Branch of the National New Drug Technology Innovation Center for Traditional Chinese Medicine.
The two parties will carry out the research and development of original and innovative traditional Chinese medicine drugs and the development of a series of health products; build a "co-introduction and sharing mechanism" for outstanding talents in the highland of traditional Chinese medicine in the Yangtze River Delta, and promote a group of outstanding talents and advantageous research projects for Tianjiang Pharmaceutical and Jiangyin Biomedical Industry. development services; establish a new regional cooperation model of "Yangtze River Delta Economic Belt-Guangdong-Hong Kong-Macao Greater Bay Area", and accelerate the industrial transformation of scientific and technological achievements in traditional Chinese medicine.
The "Academician Liu Liang - Jiangyin Traditional Chinese Medicine Industry Research Center" settled in the high-tech zone, introducing the national leading and world-class innovative product research and development system of traditional Chinese medicine into Tianjiang Pharmaceutical. This has far-reaching significance for creating an industrial ecology that integrates technology research and development, manufacturing, and medical and health services. In the future, Tianjiang Pharmaceutical will also continue to make efforts in scientific research investment, innovation and development, talent introduction, and achievement transformation to promote the high-quality development of traditional Chinese medicine.